Binding of rat IgE with the subcellular components of normal rat mast cells

Wolfgang König, Kimishige Ishizaka

Research output: Contribution to journalArticle

Abstract

Attempts were made to obtain subcellular components of rat mast cells which contain receptors for IgE. Rat peritoneal cells were treated with 125I-labeled rat IgE to label mast cells, and disrupted by ultrasonication. More than 90% of cell-bound IgE was recovered in the 20,000 g supernatant fraction which had the ability to block passive cutaneous anaphylaxis with mouse and rat reaginic antibodies. Gel-filtration of the supernatant fraction through a Sepharose 6B column showed that both radioactivity and PCA blocking activity were associated with subcellular components which were eluted in the void volume. When the 20,000 g supernatant fraction of normal peritoneal cells was incubated with 125I-rat IgE, the protein combined with the subcellular components. Incubation of the 20,000 g supernatant with an IgE-rich rat serum inhibited the binding of 125I-IgE with the components, whereas normal rat serum failed to do so. When the sepharose void volume fraction was obtained from purified mast cells and labeled with 125I, approximately 25% of radioactive material was coprecipitated with IgE-anti-IgE complexes. Evidence was obtained that subcellular components of macrophages were not coprecipitated with the antigen-antibody complexes. These results indicated that the components eluted in the void volume fraction contained receptors for IgE. In another experiment, the 20,000 g supernatant fraction was obtained from rat peritoneal cells or purified mast cells whose membrane was labeled with 125I, and fractioned by gel filtration followed by DEAE cellulose chromatography. More than 2 3 of the radioactivity and PCA-blocking activity associated with the sepharose void volume fraction were recovered in the 3 M NaCl fraction which contained 12-15% of total protein. When the 3 M fraction obtained from purified mast cells was labeled with 125I and incubated with an IgE-rich serum, a significant amount of radioactive material in the fraction was precipitated with IgE-anti-IgE complexes. The results indicate that blocking of the PCA reaction by this fraction is due to the presence of receptors for IgE.

Original languageEnglish (US)
Pages (from-to)345-353
Number of pages9
JournalImmunochemistry
Volume13
Issue number4
DOIs
StatePublished - 1976

Fingerprint

Mast Cells
Immunoglobulin E
Passive Cutaneous Anaphylaxis
IgE Receptors
Sepharose
Radioactivity
Gel Chromatography
Serum
DEAE-Cellulose Chromatography
Antigen-Antibody Complex
Proteins
Macrophages
Cell Membrane
Antibodies

ASJC Scopus subject areas

  • Molecular Biology
  • Immunology

Cite this

Binding of rat IgE with the subcellular components of normal rat mast cells. / König, Wolfgang; Ishizaka, Kimishige.

In: Immunochemistry, Vol. 13, No. 4, 1976, p. 345-353.

Research output: Contribution to journalArticle

König, Wolfgang ; Ishizaka, Kimishige. / Binding of rat IgE with the subcellular components of normal rat mast cells. In: Immunochemistry. 1976 ; Vol. 13, No. 4. pp. 345-353.
@article{474784afbc9545429c7506889deb9869,
title = "Binding of rat IgE with the subcellular components of normal rat mast cells",
abstract = "Attempts were made to obtain subcellular components of rat mast cells which contain receptors for IgE. Rat peritoneal cells were treated with 125I-labeled rat IgE to label mast cells, and disrupted by ultrasonication. More than 90{\%} of cell-bound IgE was recovered in the 20,000 g supernatant fraction which had the ability to block passive cutaneous anaphylaxis with mouse and rat reaginic antibodies. Gel-filtration of the supernatant fraction through a Sepharose 6B column showed that both radioactivity and PCA blocking activity were associated with subcellular components which were eluted in the void volume. When the 20,000 g supernatant fraction of normal peritoneal cells was incubated with 125I-rat IgE, the protein combined with the subcellular components. Incubation of the 20,000 g supernatant with an IgE-rich rat serum inhibited the binding of 125I-IgE with the components, whereas normal rat serum failed to do so. When the sepharose void volume fraction was obtained from purified mast cells and labeled with 125I, approximately 25{\%} of radioactive material was coprecipitated with IgE-anti-IgE complexes. Evidence was obtained that subcellular components of macrophages were not coprecipitated with the antigen-antibody complexes. These results indicated that the components eluted in the void volume fraction contained receptors for IgE. In another experiment, the 20,000 g supernatant fraction was obtained from rat peritoneal cells or purified mast cells whose membrane was labeled with 125I, and fractioned by gel filtration followed by DEAE cellulose chromatography. More than 2 3 of the radioactivity and PCA-blocking activity associated with the sepharose void volume fraction were recovered in the 3 M NaCl fraction which contained 12-15{\%} of total protein. When the 3 M fraction obtained from purified mast cells was labeled with 125I and incubated with an IgE-rich serum, a significant amount of radioactive material in the fraction was precipitated with IgE-anti-IgE complexes. The results indicate that blocking of the PCA reaction by this fraction is due to the presence of receptors for IgE.",
author = "Wolfgang K{\"o}nig and Kimishige Ishizaka",
year = "1976",
doi = "10.1016/0019-2791(76)90346-3",
language = "English (US)",
volume = "13",
pages = "345--353",
journal = "Molecular Immunology",
issn = "0161-5890",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - Binding of rat IgE with the subcellular components of normal rat mast cells

AU - König, Wolfgang

AU - Ishizaka, Kimishige

PY - 1976

Y1 - 1976

N2 - Attempts were made to obtain subcellular components of rat mast cells which contain receptors for IgE. Rat peritoneal cells were treated with 125I-labeled rat IgE to label mast cells, and disrupted by ultrasonication. More than 90% of cell-bound IgE was recovered in the 20,000 g supernatant fraction which had the ability to block passive cutaneous anaphylaxis with mouse and rat reaginic antibodies. Gel-filtration of the supernatant fraction through a Sepharose 6B column showed that both radioactivity and PCA blocking activity were associated with subcellular components which were eluted in the void volume. When the 20,000 g supernatant fraction of normal peritoneal cells was incubated with 125I-rat IgE, the protein combined with the subcellular components. Incubation of the 20,000 g supernatant with an IgE-rich rat serum inhibited the binding of 125I-IgE with the components, whereas normal rat serum failed to do so. When the sepharose void volume fraction was obtained from purified mast cells and labeled with 125I, approximately 25% of radioactive material was coprecipitated with IgE-anti-IgE complexes. Evidence was obtained that subcellular components of macrophages were not coprecipitated with the antigen-antibody complexes. These results indicated that the components eluted in the void volume fraction contained receptors for IgE. In another experiment, the 20,000 g supernatant fraction was obtained from rat peritoneal cells or purified mast cells whose membrane was labeled with 125I, and fractioned by gel filtration followed by DEAE cellulose chromatography. More than 2 3 of the radioactivity and PCA-blocking activity associated with the sepharose void volume fraction were recovered in the 3 M NaCl fraction which contained 12-15% of total protein. When the 3 M fraction obtained from purified mast cells was labeled with 125I and incubated with an IgE-rich serum, a significant amount of radioactive material in the fraction was precipitated with IgE-anti-IgE complexes. The results indicate that blocking of the PCA reaction by this fraction is due to the presence of receptors for IgE.

AB - Attempts were made to obtain subcellular components of rat mast cells which contain receptors for IgE. Rat peritoneal cells were treated with 125I-labeled rat IgE to label mast cells, and disrupted by ultrasonication. More than 90% of cell-bound IgE was recovered in the 20,000 g supernatant fraction which had the ability to block passive cutaneous anaphylaxis with mouse and rat reaginic antibodies. Gel-filtration of the supernatant fraction through a Sepharose 6B column showed that both radioactivity and PCA blocking activity were associated with subcellular components which were eluted in the void volume. When the 20,000 g supernatant fraction of normal peritoneal cells was incubated with 125I-rat IgE, the protein combined with the subcellular components. Incubation of the 20,000 g supernatant with an IgE-rich rat serum inhibited the binding of 125I-IgE with the components, whereas normal rat serum failed to do so. When the sepharose void volume fraction was obtained from purified mast cells and labeled with 125I, approximately 25% of radioactive material was coprecipitated with IgE-anti-IgE complexes. Evidence was obtained that subcellular components of macrophages were not coprecipitated with the antigen-antibody complexes. These results indicated that the components eluted in the void volume fraction contained receptors for IgE. In another experiment, the 20,000 g supernatant fraction was obtained from rat peritoneal cells or purified mast cells whose membrane was labeled with 125I, and fractioned by gel filtration followed by DEAE cellulose chromatography. More than 2 3 of the radioactivity and PCA-blocking activity associated with the sepharose void volume fraction were recovered in the 3 M NaCl fraction which contained 12-15% of total protein. When the 3 M fraction obtained from purified mast cells was labeled with 125I and incubated with an IgE-rich serum, a significant amount of radioactive material in the fraction was precipitated with IgE-anti-IgE complexes. The results indicate that blocking of the PCA reaction by this fraction is due to the presence of receptors for IgE.

UR - http://www.scopus.com/inward/record.url?scp=0017240092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017240092&partnerID=8YFLogxK

U2 - 10.1016/0019-2791(76)90346-3

DO - 10.1016/0019-2791(76)90346-3

M3 - Article

VL - 13

SP - 345

EP - 353

JO - Molecular Immunology

JF - Molecular Immunology

SN - 0161-5890

IS - 4

ER -